Anu Puri

Anu Puri

Auto-generated profile, based on publicly available information

Anu Puri

RNA Structure and Design Section, RNA Biology Laboratory (RBL), Center for Cancer Research, NCI-Frederick, NIH, Frederick, USA

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Journal of Controlled Release
Verified
Journal Article
Closed access
MAMukta Agrawal
Mukta Agrawal
SSShailendra Saraf
Shailendra Saraf
SSSwarnlata Saraf
Swarnlata Saraf
SDSunil K. Dubey
Sunil K. Dubey
APAnu Puri
Anu Puri
AAAmit Alexander
Amit Alexander

1 May 2020 in Journal of Controlled Release
Verified
Journal Article
Closed access
MAMukta Agrawal
Mukta Agrawal
Swarnlata SarafSwarnlata Saraf
Swarnlata Saraf
SSShailendra Saraf
Shailendra Saraf
SDSunil Kumar Dubey
Sunil Kumar Dubey
APAnu Puri
Anu Puri
AAAmit Alexander
Amit Alexander

1 September 2021 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
AKAchalla Vaishnav Pavan Kumar
Achalla Vaishnav Pavan Kumar
SDSunil Dubey
Sunil Dubey
Sanjay TiwariSanjay Tiwari
Sanjay Tiwari
APAnu Puri
Anu Puri
SHSiddhanth Hejmady
Siddhanth Hejmady
PKPrashant Kesharwani
Prashant Kesharwani

23 October 2020 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
TWTejashree Waghule
Tejashree Waghule
VRVamshi Krishna Rapalli
Vamshi Krishna Rapalli
SGSrividya Gorantla
Srividya Gorantla
RSRanendra Narayan Saha
Ranendra Narayan Saha
SDSunil Dubey
Sunil Dubey
GSGautam Singhvi
Gautam Singhvi
Background: Skin diseases affect all the age groups of people and have an impact on patients’ physical, mental, and emotional status. Conventional topical preparation is limited with its efficacy due to low permeation, frequent application, and poor adherence to the therapy for prolong time. Objective: The objective of this review article is to address the emerging trends of nanotechnology derived lipidic carrier systems for an effective treatment for skin disorders. Methodology: Various research and review articles from reputed international journals were referred and compiled. Results and Discussion: opical drug delivery systems were found to be more effective than oral and parenteral drug delivery systems for treating skin diseases due to targeted localized applications with reduced side effects. Lipid-based nanoparticles have been found to have the potential in treating skin diseases due to the biocompatibility and the versatility of the lipids. Nanostructured lipid carriers (NLCs) have gained much attention in treating skin diseases due to improved stability of the drugs, enhanced skin permeation, retention, and better therapeutic efficacy. The review summarizes the NLCs characteristics and their application for topical delivery of various therapeutics in skin disorders. NLCs have shown great potential in effective drug delivery for the treatment of psoriasis, dermatitis, bacterial infections, and skin cancer. Its cosmetic application has opened a new area for skincare. Furthermore, safety and clinical status revealed its future commercial acceptability. Conclusion: NLCs have been found as effective lipid nanocarriers for the delivery of topical therapeutics.


1 January 2017 in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
Verified
Journal Article
Closed access
KSKrishna Pal Singh
Krishna Pal Singh
NDNeeraj Singh Dhek
Neeraj Singh Dhek
ANAnuj Nehra
Anuj Nehra
SASweeti Ahlawat
Sweeti Ahlawat
APAnu Puri
Anu Puri